False-negative hybrid capture II results related to altered adhesion molecule distribution in women with atypical squamous cells Pap smear results and tissue-based human papillomavirus-positive high-grade cervical intraepithelial neoplasia

Journal of Lower Genital Tract Disease

Volumn 8, Issue 4, 2004, Pages 285-291

  Lonky, Neal M ^a,b,e   Felix, Juan ^c   Tsadik, Girma Wolde ^a   Lonky, Stewart ^d  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Trylon Corporation   (United States)

^e NONE   (United States)

Author keywords

Adhesion molecule; Atypical squamous cells; Cervical intraepithelial neoplasia; Human papillomavirus

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; UVOMORULIN; VIRUS DNA;

ARTICLE; COLPOSCOPY; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; SQUAMOUS CELL; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 4944264944     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200410000-00005     Document Type: Article

References (35)

1. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
2. Nobbenhuis MA, Walboomers JMM, Helmerhorst TJM, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20-25.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
4. Cox JT. Clinical role of HPV testing. Obstet Gynecol Clin North Am 1996;23:811-51.
5. Wright TC Jr, Cox TJ, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120-9.
6. Schiffman M, Herrero R, Hildersheim A, Sherman M, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: Results from women in a high risk province of Costa Rica. JAMA 2000;283:87-93.
7. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-10.
8. ALTS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
9. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol 1997;177:930-6.
10. Kuhn L, Denny L, Pollock A, Lorincz A, Richart RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-25.
11. Infantoino C, Fabris P, Infantolino D, Biasin MR, Venza E, Tositti G, et al. Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases. Eur J Obstet Gynecol Reprod Biol 2000;93:71-5.
12. Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol 2003;101:481-9.
13. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57.
14. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance. J Natl Cancer Inst 2001;93:293-9.
15. Pretorius RG, Peterson P, Navack S, Azizi F, Sadeghi MK, Lorincz A. Comparison of two signal-amplification DNA tests for high risk HPV as an aid to colposcopy. J Reprod Med 2002:47:290-6.
16. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
17. Loiudice L, Abbiati R, Boselli F, Cecchini G, Costa S, Grossi E, et al. Improvement of cytology sensitivity using a visual adjunctive procedure: a co-operative Italian study on speculoscopy (GISPE). Eur J Cancer Prev 1998;7:295-304.
18. Wertlake PT, Francus K, Newkirk G, Parham G. Effectiveness of the Pap smear and speculoscopy as compared with speculoscopy alone: a community based clinical trial. Obstet Gynecol 1997;90:421-7.
19. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
20. Hutchinson ML, Agarwal P, Denault T, Berger B, Cibas ES. A new look at cervical cytology: ThinPrep multicenter trial results. Acta Cytol 1992;36:499-504.
21. Wright TC Jr, Denny L, Kuhn L, Goldie S. Use of visual screening methods for cervical cancer screening. Obstet Gynecol Clin North Am. 2002;29:701-34.
22. Felix JC, Lonky NM, Tamura K, Yu KJ, Naidu Y, Lai, C-R, et al. Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with false negative Pap smear. Am J Obstet Gynecol 2002;186:1308-14.
23. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153: 1731-9.
24. Felix JC. The science behind the effectiveness of in vivo screening. Am J Obstet Gynecol 2003;188(3 suppl):S8-12.
25. Wright VC, Chapman W. Intraepithelial neoplasia of the lower female genital tract: etiology, investigation, and management. Semin Surg Oncol 1992;8:180-90.
26. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002;20:1080-5.
27. Schiffman MR, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
28. Brown DR, Rawlings K, Handy V, Fife K, Bryan JT, Cramer H, et al. Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens. J Med Virol 1966;48:210-4.
29. Sigurdsson K, Arnadottir T, Snorradottir M, Benediktsdottir M, Saemunddsson H. Human papillomavirus (HPV) in an Icelandic population: the role of HPV DNA testing based on hybrid capture and PCR assays among women with screen-detected abnormal Pap smears. Int J Cancer 1997; 72:446-52.
30. Adams CL, Nelson WJ, Smith SJ. Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion. J Cell Biol 1996;135:1899-911.
31. Vessey C, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995;176:151-9.
32. deBoer CJ, van Dorst E, van Krieken H, Jansen-van Rhijn C, Warnaar S, Fleuren G, et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol 1999;155: 505-15.
33. Takeichi M. Morphologic roles of classic cadherins. Curr Opin Cell Biol 1995;7:619-27.
34. Wu H, Lotan R, Menter D, Lippman SM, Xu XC. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 2000; 20:1385-90.
35. Nasu K, Narahara H, Etoh Y, Kawano Y, Hirota Y, Miyakawa I. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and the expression of ICAM-1 mRNA in uterine cervical cancer. Gynecol Oncol 1997;65:304-8.